无糖尿病成人中使用胰高血糖素样肽-1受体激动剂者的重复食管胃十二指肠镜率:一项回顾性匹配队列研究
该回顾性匹配队列研究利用TriNetX平台分析体重指数≥27 kg/m²且无糖尿病的成人,比较有≥3次GLP-1RA处方者与从未处方GLP-1RA但使用其他减重药物者重复EGD及新发胃轻瘫诊断的风险。结果显示两组重复EGD(5.4% vs 4.2%;RR 1.28;95%CI 0.95-1.71)和新发胃轻瘫(1.1% vs 0.6%;RR 2.00;95%CI 0.94-4.27)均无显著差异。结论认为GLP-1RA可能不会实质性增加无糖尿病个体重复内镜的风险。
要点
- 无糖尿病成人中,GLP-1RA组重复EGD发生率为5.4%,对照组为4.2%,RR 1.28(95%CI 0.95-1.71),无显著差异。
- 新发胃轻瘫诊断率GLP-1RA组1.1%,对照组0.6%,RR 2.00(95%CI 0.94-4.27),无显著差异。
- GLP-1RA可能不会实质性增加无糖尿病个体重复内镜的风险。
核心结论
- GLP-1RA可能不会实质性增加无糖尿病个体重复内镜的风险。
研究设计与样本
- 回顾性匹配病例对照研究,使用TriNetX健康研究平台分析体重指数≥27 kg/m²且无糖尿病的成人。
- 研究组为有≥3次GLP-1RA处方且在初始GLP-1RA处方≥30天后接受EGD者;对照组为从未处方GLP-1RA但在其他减重药物处方后接受EGD者。
- 采用匹配队列中的风险比(RR)比较结局。
主要发现
- 重复EGD发生率:GLP-1RA组5.4% vs 对照组4.2%;RR 1.28;95%CI 0.95-1.71,无显著差异。
- 新发胃轻瘫诊断率:GLP-1RA组1.1% vs 对照组0.6%;RR 2.00;95%CI 0.94-4.27,无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Data on endoscopic outcomes in adults without diabetes who are taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) are limited. Therefore, we compared repeat EGD in this population with those not taking GLP-1RAs using a retrospective matched case-control study. METHODS: Using the TriNetX health research platform (Cambridge, Mass, USA), we analyzed adults with a body mass index ≥27 kg/m2 without diabetes who underwent diagnostic EGD. The study group included individuals with ≥3 GLP-1RA prescriptions and undergoing EGD ≥30 days after the initial GLP-1RA prescription. The control group included individuals who were never prescribed GLP-1RAs but had an EGD after the prescription of other weight loss medications. Outcomes were compared using the risk ratio (RR) in matched cohorts. RESULTS: No significant difference in repeat EGD (5.4% vs 4.2%; RR, 1.28; 95% confidence interval [CI], .95-1.71) or new diagnosis of gastroparesis (1.1% vs .6%; RR; 2.00; 95% CI, .94-4.27) was noted between the groups. CONCLUSIONS: GLP-1RAs may not substantially increase the risk of repeat endoscopy in individuals without diabetes.
引用
- Elangovan A, Aggarwal P, Kaelber DC, et al. Rates of repeat EGD in nondiabetic adults with glucagon-like peptide-1 receptor agonist prescription: a retrospective matched cohort study. Gastrointest Endosc. 2024. PMID: 39389433. doi:10.1016/j.gie.2024.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。